2025 EAU Prostate Cancer Guidelines update: High risk, locally advanced and biochemical recurrence
UROONCO PCa chief editor Dr. Giancarlo Marra talks to Prof. Derya Tilki on the 2025 updates in the EAU Prostate Cancer Guidelines, specifically for high risk, locally advanced and biochemical recurrence.
▶︎
Expert discussion on treatment of biochemical recurrence in prostate cancer
▶︎
2025 EAU Prostate Cancer Guidelines update: Diagnosis and localised disease
▶︎
AUA Advanced Prostate Cancer Course Webcast (2025)
▶︎
New Advances in Prostate Cancer in 2025
▶︎
Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows
▶︎
Biochemical Recurrence After Radical Prostatectomy with Dr. Pavlovich
▶︎
Prostate Cancer: PSA Recurrence and Risk Assessment
▶︎
Gleason 3+4 Prostate Cancer
▶︎
Prostate Cancer: PSMA PET and Functional Imaging
▶︎
Metastases with a Low PSA, What is PSA Doubling Time | Answering YouTube Comments #57 | PCRI
▶︎
How US Air Force B 52 Pilot Performed an Emergency Takeoff at Full Speed
▶︎
Treatment recommendations for high-risk biochemical recurrent prostate cancer
▶︎
AUA Guidelines on Early Detection of Prostate Cancer Webcast (2025)
▶︎
Radiation therapy for prostate cancer: the basics
▶︎
2025 ASCO Prostate Cancer Highlights
▶︎
High-risk prostate cancer: what patients and physicians should know in 2026
▶︎
Managing Prostate Cancer Recurrence After Radical Prostatectomy with Dr. Adam S. Kibel, MD
▶︎
Advanced Treatments in 2025 Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 7
▶︎
New Draft 2025 Clinical Practice Guidelines for the Early Detection of Prostate Cancer
▶︎